These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 10401633)
1. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Bechmann I; Mor G; Nilsen J; Eliza M; Nitsch R; Naftolin F Glia; 1999 Jul; 27(1):62-74. PubMed ID: 10401633 [TBL] [Abstract][Full Text] [Related]
2. Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration. Bechmann I; Lossau S; Steiner B; Mor G; Gimsa U; Nitsch R Glia; 2000 Oct; 32(1):25-41. PubMed ID: 10975908 [TBL] [Abstract][Full Text] [Related]
3. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. Beer R; Franz G; Schöpf M; Reindl M; Zelger B; Schmutzhard E; Poewe W; Kampfl A J Cereb Blood Flow Metab; 2000 Apr; 20(4):669-77. PubMed ID: 10779011 [TBL] [Abstract][Full Text] [Related]
4. Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection. Elovaara I; Sabri F; Gray F; Alafuzoff I; Chiodi F Acta Neuropathol; 1999 Oct; 98(4):355-62. PubMed ID: 10502040 [TBL] [Abstract][Full Text] [Related]
5. Peripheral LPS administrations up-regulate Fas and FasL on brain microglial cells: a brain protective or pathogenic event? Terrazzino S; Bauleo A; Baldan A; Leon A J Neuroimmunol; 2002 Mar; 124(1-2):45-53. PubMed ID: 11958821 [TBL] [Abstract][Full Text] [Related]
6. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. Lu L; Qian S; Hershberger PA; Rudert WA; Lynch DH; Thomson AW J Immunol; 1997 Jun; 158(12):5676-84. PubMed ID: 9190916 [TBL] [Abstract][Full Text] [Related]
7. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844 [TBL] [Abstract][Full Text] [Related]
8. The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas. Gutierrez LS; Eliza M; Niven-Fairchild T; Naftolin F; Mor G Breast Cancer Res Treat; 1999 Apr; 54(3):245-53. PubMed ID: 10445423 [TBL] [Abstract][Full Text] [Related]
9. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer. Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988 [TBL] [Abstract][Full Text] [Related]
10. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320 [TBL] [Abstract][Full Text] [Related]
11. Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. Kwidzinski E; Mutlu LK; Kovac AD; Bunse J; Goldmann J; Mahlo J; Aktas O; Zipp F; Kamradt T; Nitsch R; Bechmann I J Neural Transm Suppl; 2003; (65):29-49. PubMed ID: 12946047 [TBL] [Abstract][Full Text] [Related]
12. Regulation of Fas and FasL expression on rat Schwann cells. Wohlleben G; Ibrahim SM; Schmidt J; Toyka KV; Hartung HP; Gold R Glia; 2000 Jun; 30(4):373-81. PubMed ID: 10797617 [TBL] [Abstract][Full Text] [Related]
13. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Hamann KJ; Dorscheid DR; Ko FD; Conforti AE; Sperling AI; Rabe KF; White SR Am J Respir Cell Mol Biol; 1998 Oct; 19(4):537-42. PubMed ID: 9761749 [TBL] [Abstract][Full Text] [Related]
14. Fas ligand mRNA expression in the mouse central nervous system. Shin DH; Lee E; Kim HJ; Kim S; Cho SS; Chang KY; Lee WJ J Neuroimmunol; 2002 Feb; 123(1-2):50-7. PubMed ID: 11880149 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD95 and CD95L on astrocytes in the CA1 area of the immature rat hippocampus after hypoxia-ischemia injury. Kim MJ; Lim HS; Yoo YB; Lee YI; Hahm DH; Lee HJ; Jung KW; Kim JW; Yoe SM; Chung DC; Chang YP Comp Med; 2007 Dec; 57(6):581-9. PubMed ID: 18246871 [TBL] [Abstract][Full Text] [Related]
16. Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway. Yao G; Hou Y Int Immunopharmacol; 2004 Feb; 4(2):213-21. PubMed ID: 14996413 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus. Baloul L; Camelo S; Lafon M J Neurovirol; 2004 Dec; 10(6):372-82. PubMed ID: 15765808 [TBL] [Abstract][Full Text] [Related]
18. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493 [TBL] [Abstract][Full Text] [Related]
19. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Chrousos GP; Koutras DA Thyroid; 2000 Jul; 10(7):527-32. PubMed ID: 10958304 [TBL] [Abstract][Full Text] [Related]
20. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]